VEA
IDYA icon

Virtus ETF Advisers’s IDEAYA Biosciences IDYA Stock Holding History

Virtus ETF Advisers’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,758
Closed -$70.9K – 592
2024
Q4 		$70.9K Buy
2,758
+389
+16% +$11K 0.03% 367
2024
Q3 		$75K Buy
2,369
+44
+2% +$1.67K 0.04% 418
2024
Q2 		$81.6K Sell
2,325
-210
-8% -$8.32K 0.04% 398
2024
Q1 		$111K Sell
2,535
-170
-6% -$7.31K 0.06% 351
2023
Q4 		$96.2K Sell
2,705
-1,272
-32% -$38K 0.06% 375
2023
Q3 		$107K Sell
3,977
-401
-9% -$10.2K 0.07% 328
2023
Q2 		$103K Sell
4,378
-1,594
-27% -$32.8K 0.06% 369
2023
Q1 		$82K Sell
5,972
-2,287
-28% -$38.1K 0.05% 382
2022
Q4 		$150K Sell
8,259
-897
-10% -$15.1K 0.08% 345
2022
Q3 		$137K Buy
9,156
+68
+0.7% +$883 0.05% 366
2022
Q2 		$125K Buy
9,088
+1,896
+26% +$21.1K 0.05% 371
2022
Q1 		$80K Sell
7,192
-430
-6% -$6.34K 0.04% 336
2021
Q4 		$180K Sell
7,622
-2,053
-21% -$47.7K 0.07% 248
2021
Q3 		$247K Sell
9,675
-502
-5% -$11.7K 0.11% 220
2021
Q2 		$214K Buy
+10,177
New +$209K 0.09% 293

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Virtus ETF Advisers's IDYA Position: Q1 2025 in Review

Virtus ETF Advisers sold out of IDEAYA Biosciences (IDYA) in Q1 2025, closing a stake of 2,758 shares — an estimated $70.9K sold.

Virtus ETF Advisers first reported a position in IDYA in Q2 2021 and held it in 15 quarters. The position peaked at $247K in Q3 2021. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

  • Virtus ETF Advisers reported no remaining IDEAYA Biosciences position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 2,758 IDEAYA Biosciences shares in Q1 2025, an estimated $70.9K.
  • Virtus ETF Advisers first reported a position in IDEAYA Biosciences in Q2 2021 and held it in 15 quarters.
  • Virtus ETF Advisers's IDEAYA Biosciences position peaked at $247K in Q3 2021.
  • 207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.